(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 587.9MM | +6% |
Gross Profit | 171.6MM | -7% |
Cost Of Revenue | 416.3MM | - |
Operating Income | -12.2MM | -153% |
Operating Expenses | 183.8MM | +14% |
Net Income | -17.1MM | -337% |
R&D | 22.4MM | +7% |
G&A | 154.6MM | +4% |
Amortization | 33.3MM | -0% |
Interest Expense | 31.9MM | +32% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024. ICU Medical’s presentation will be on Wednesday, March 20, 2024 at 11:15 a.m. PT (2:15 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, March 2
The company fixed the issues, which are linked to one reported injury, by updating its software.
SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024. ICU Medical’s presentation will be on Monday, March 4, 2024 at 4:30 a.m. PT (7:30 a.m. ET). Company management will also be participating in one-on-one meetin
Investors in ICU Medical, Inc. ( NASDAQ:ICUI ) had a good week, as its shares rose 6.1% to close at US$109 following...
ICU Medical, Inc. (NASDAQ:ICUI) Q4 2023 Earnings Call Transcript February 27, 2024 ICU Medical, Inc. misses on earnings expectations. Reported EPS is $-0.71031 EPS, expectations were $1.18. ICU Medical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
Q4 2023 ICU Medical Inc Earnings Call
ICU Medical and Ardmore Shipping are part of the Zacks Screen of the Week article.
ICU Medical (ICUI) delivered earnings and revenue surprises of 33.05% and 4.09%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Revenue Sees Slight Increase While Net Loss Widens Year-Over-Year
SAN CLEMENTE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2023. Fourth Quarter 2023 Results Fourth quarter 2023 revenue was $587.9 million, compared to $578.0 million in the same period in the prior year. GAAP gross profit for the fourth quarter of 2023 was $171.6 million, as compared to $174.9 million in the same pe